Arcellx, Inc.·4

Jan 20, 7:59 PM ET

Lubner David Charles 4

4 · Arcellx, Inc. · Filed Jan 20, 2026

Insider Transaction Report

Form 4
Period: 2026-01-20
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-20$6.28/sh+6,000$37,68027,659 total
  • Sale

    Common Stock

    [F1]
    2026-01-20$75.00/sh6,000$450,00021,659 total
  • Exercise/Conversion

    Stock Option (right to buy)

    [F2]
    2026-01-206,00059,405 total
    Exercise: $6.28Exp: 2031-06-09Common Stock (6,000 underlying)
Footnotes (2)
  • [F1]The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 29, 2025.
  • [F2]Shares issued pursuant to the Issuer's 2017 Equity Incentive Plan (the "2017 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2017 Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean June 9, 2021.
Signature
/s/ Michelle Gilson, as Attorney-in-Fact|2026-01-20

Documents

1 file
  • 4
    ownership.xmlPrimary

    4